Despite our prostate cancer patients being more likely to report low #financialtoxicity, those with high FT were still more likely to engage in cost-coping mechanisms like delaying or avoiding medical care and reducing spending on leisure, which can negatively impact outcomes and QoL

Excited to share our findings regarding #financialtoxicity of our patients with prostate cancer presenting for #radiationtherapy @bidmc-cancercenter.bsky.social @bidmcreseach.bsky.social ! And excited to learn more about delivery of quality care and barriers to cancer care at #ASCOQLTY25!

#ASTRO25 ! Thank you for the opportunity to present our work on #financialtoxicity in patients undergoing radiation treatment, specifically on baseline FT and cost-coping mechanisms. Stay tuned for #ASCOQLTY25 for subanalysis on our prostate cancer patient cohort! #radonc

Day 3 of #ASCO25 ! Honored to be presenting on how social determinants of health affect immunotherapy use in Stage III NSCLC patients after definitive chemoradiation @ascocancer.bsky.social @bidmcreseach.bsky.social @bidmc-cancercenter.bsky.social #TuftsMedicalCenter

Day 2 of #ASCO25! Exciting new frontiers in harnessing power of AI to better cancer care! As Dr. Robin Zon, President of @ascocancer.bsky.social, & Ms. Ruth Porat, President & CIO of Google and Alphabet, mentioned, AI is augmenting human capabilities, and it's about using it as an agent for change

Thrilled to be at #ASCO25 ! Excited to witness and be a part of the forefront of cancer research! And honored to present research @ascocancer.bsky.social

📣 Big shoutout to our faculty at #TuftsMedicine & @bidmc-cancercenter.bsky.social radiation oncology residency, Dr. Jang and Dr. Huber, for being speaker and moderator at this year's @astro-org.bsky.social Annual RefresherCourse! Thank you for all that you do for us and for the #radonc community!